Doctor Yuling Hsu
National Cheng Kung University Hospital, Tainan (Taiwan)
Sacubitril/valsartan in primary prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.
Event: ESC Congress 2024
Topic: Cardio-Oncology
Session: Smaller trials: cardiac function and remodelling
